Monitoring Accumulating Data in a Clinical Trial
From MaRDI portal
Publication:3201535
DOI10.2307/2531771zbMATH Open0715.62235OpenAlexW2008860560WikidataQ30976844 ScholiaQ30976844MaRDI QIDQ3201535FDOQ3201535
Publication date: 1989
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531771
Recommendations
- STATISTICAL METHODS FOR MONITORING CLINICAL TRIALS
- On the inefficiency of the adaptive design for monitoring clinical trials
- Statistical monitoring of clinical trials. Fundamentals for investigators.
- Monitoring Clinical Trials Based on Predictive Probability of Significance
- scientific article; zbMATH DE number 3963045
likelihoodsurvival analysisinterim analysissequential analysisclinical trialBayes' theoremearly stoppingaccounting for patients' prognosescovariate analysis
Cited In (6)
- BAYES DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL TRIALS
- Data Monitoring in Clinical Trials
- Nonmyopic and pseudo-nonmyopic approaches to optimal sequential design in the presence of covariates
- A Bayesian Group Sequential Approach for Multiple Endpoints
- Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
- Bayes optimal sequential trial designs
This page was built for publication: Monitoring Accumulating Data in a Clinical Trial
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201535)